Harlan W. Waksal's most recent trade in Lyra Therapeutics Inc was a trade of 128,333 Performance-based Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyra Therapeutics Inc | Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 128,333 | 0 | - | - | Performance-based Restricted Stock Units | |
| Lyra Therapeutics Inc | Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 275,000 | 536,966 | - | 0 | Common Stock | |
| Lyra Therapeutics Inc | Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 953,002 | 953,002 | - | - | Stock Option | |
| Lyra Therapeutics Inc | Harlan W. Waksal | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 4.22 per share. | 12 Apr 2022 | 236,966 | 236,966 | - | 4.2 | 999,997 | Common Stock |
| Lyra Therapeutics Inc | Harlan W. Waksal | Director, Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 520,000 | 520,000 | - | - | Stock Option |